Location History:
- Glen Mills, PA (US) (1993 - 1997)
- Wilmington, DE (US) (1992 - 2014)
Company Filing History:
8 out of 16,338 
4 out of 234 
3 out of 3,684 
Years Active: 1992-2014
Absolutely, here is the article for you:
Title: George L Trainor: Pioneering Innovations in HIV Treatment and Kinase Inhibition
Introduction:
George L Trainor, a visionary inventor based in Wilmington, DE, has made significant contributions to the field of pharmacology with his groundbreaking patents and research endeavors. With a total of 17 patents to his name, Trainor has played a crucial role in developing innovative solutions for treating various diseases, particularly human immunodeficiency virus (HIV) infection and kinase-associated conditions.
Latest Patents:
Trainor's latest patents showcase his expertise in developing novel inhibitors of HIV replication and kinase inhibitors. His work on compounds of formula I for treating HIV infection and pyrrolotriazine derivatives for treating kinase-associated conditions demonstrates his commitment to advancing medical treatments through cutting-edge pharmaceutical compositions and methods.
Career Highlights:
During his illustrious career, George L Trainor has worked with renowned companies such as E.I. du Pont de Nemours and Company (DuPont) and Bristol-Myers Squibb Pharma Company. His time at these esteemed organizations has provided him with invaluable experience and resources to further his research and development efforts in the field of healthcare innovation.
Collaborations:
Trainor has collaborated closely with esteemed professionals in the industry, including his coworkers Robert F Kaltenbach and Frank W Hobbs. Together, they have worked tirelessly to bring forth revolutionary advancements in pharmacology and drug development, leveraging their collective expertise to push the boundaries of scientific discovery.
Conclusion:
In conclusion, George L Trainor stands as a trailblazing inventor whose dedication to innovation has led to groundbreaking advancements in the treatment of HIV infection and kinase-associated conditions. His patented inventions serve as a testament to his unwavering commitment to improving global health outcomes and shaping the future of pharmaceutical research.